HUP9901360A2 - Cimicifuga racemosa-ból származó extraktum alkalmazása - Google Patents

Cimicifuga racemosa-ból származó extraktum alkalmazása

Info

Publication number
HUP9901360A2
HUP9901360A2 HU9901360A HUP9901360A HUP9901360A2 HU P9901360 A2 HUP9901360 A2 HU P9901360A2 HU 9901360 A HU9901360 A HU 9901360A HU P9901360 A HUP9901360 A HU P9901360A HU P9901360 A2 HUP9901360 A2 HU P9901360A2
Authority
HU
Hungary
Prior art keywords
cimicifuga racemosa
racemosa extract
extract
cimicifuga
estrogen
Prior art date
Application number
HU9901360A
Other languages
English (en)
Inventor
Cornelia Bodinet
Johannes Freudenstein
Thomas Nesselhut
Peter Schneider
Original Assignee
Schaper & Brümmer GmbH & Co. KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schaper & Brümmer GmbH & Co. KG filed Critical Schaper & Brümmer GmbH & Co. KG
Publication of HUP9901360A2 publication Critical patent/HUP9901360A2/hu
Publication of HUP9901360A3 publication Critical patent/HUP9901360A3/hu
Publication of HU224316B1 publication Critical patent/HU224316B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Abstract

™sztrőgénfüggő tűmőrők kezelésére általánősan használt antiösztrőgénhatóanyag hatását egy Cimicifűga racemősa extraktűm egyidejű beadásamegnöveli, előnyösen napőnként 5 mg és 500 mg közötti gyógyászatikészítmény adagőlása esetén. ŕ
HU9901360A 1996-12-14 1997-12-12 Cimicifuga racemosából származó extraktum alkalmazása antitumor hatású gyógyszerkészítmények elõállítására HU224316B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652183A DE19652183C1 (de) 1996-12-14 1996-12-14 Verwendung eines Extraktes aus Cimicifuga racemosa
PCT/DE1997/002898 WO1998026791A1 (de) 1996-12-14 1997-12-12 Verwendung eines extraktes aus cimicifuga racemosa

Publications (3)

Publication Number Publication Date
HUP9901360A2 true HUP9901360A2 (hu) 1999-08-30
HUP9901360A3 HUP9901360A3 (en) 2000-02-28
HU224316B1 HU224316B1 (hu) 2005-07-28

Family

ID=7814802

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901360A HU224316B1 (hu) 1996-12-14 1997-12-12 Cimicifuga racemosából származó extraktum alkalmazása antitumor hatású gyógyszerkészítmények elõállítására

Country Status (13)

Country Link
US (1) US6267994B1 (hu)
EP (1) EP0847755B1 (hu)
AT (1) ATE205721T1 (hu)
AU (2) AU730372B2 (hu)
CA (1) CA2245890C (hu)
DE (2) DE19652183C1 (hu)
DK (1) DK0847755T3 (hu)
ES (1) ES2163085T3 (hu)
HU (1) HU224316B1 (hu)
IL (1) IL125776A (hu)
NO (1) NO316106B1 (hu)
PL (1) PL187264B1 (hu)
WO (1) WO1998026791A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
ATE303814T1 (de) * 1999-07-15 2005-09-15 Uinv Kobenhavns Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos
DE10054641A1 (de) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
DE10146159A1 (de) 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
DE10206390A1 (de) * 2002-02-15 2003-08-28 Bionorica Ag Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten
US20030224069A1 (en) * 2002-06-03 2003-12-04 Ven Subbiah Triterpene glycosides for hormonal therapy
US20030224068A1 (en) * 2002-06-03 2003-12-04 Ven Subbiah Compounds for hormonal therapy
EP1519717B1 (en) * 2002-07-05 2010-09-29 Temrel Limited Controlled release composition
US20090264377A1 (en) * 2002-12-27 2009-10-22 Linda Saxe Einbond Anti-neoplastic compositions comprising extracts of black cohosh
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20090186837A1 (en) 2002-12-27 2009-07-23 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
JP2004307445A (ja) * 2003-04-02 2004-11-04 Pharmaton Sa Ｓｅｒｍの副作用を改善する方法
US20040228931A1 (en) * 2003-05-12 2004-11-18 Pharmachem Laboratories, Inc. Novel composition for hormonal balance and uses thereof
EP1644015B1 (en) * 2003-07-01 2008-02-27 Max Zeller Söhne AG Plant extraction method and extract
DE102005005276A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Chemoprävention der Tumorgenese und/oder zur Inhibition der Tumorprogression bei endokrin-abhängigen und endokrin-unabhängigen Tumoren
KR20150016373A (ko) 2012-07-03 2015-02-11 막스 젤러 죈네 악티엔게젤샤프트 시미시푸가 추출물의 신규한 약학적 용도
EP3906040A1 (en) * 2018-12-31 2021-11-10 Max Zeller Söhne AG Combination of cimicifuga and petasites extracts for anticancer therapy and prophylaxis
IT201900000343A1 (it) 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02255622A (ja) * 1989-03-28 1990-10-16 Tsumura & Co 制癌補助剤
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders

Also Published As

Publication number Publication date
CA2245890C (en) 2010-05-25
ATE205721T1 (de) 2001-10-15
DK0847755T3 (da) 2001-11-12
PL187264B1 (pl) 2004-06-30
PL323617A1 (en) 1998-06-22
NO316106B1 (no) 2003-12-15
IL125776A0 (en) 1999-04-11
US6267994B1 (en) 2001-07-31
ES2163085T3 (es) 2002-01-16
AU5549098A (en) 1998-07-15
NO975858D0 (no) 1997-12-12
EP0847755B1 (de) 2001-09-19
CA2245890A1 (en) 1998-06-25
DE59704654D1 (de) 2001-10-25
HU224316B1 (hu) 2005-07-28
WO1998026791A1 (de) 1998-06-25
AU730372B2 (en) 2001-03-08
EP0847755A1 (de) 1998-06-17
HUP9901360A3 (en) 2000-02-28
AU4830097A (en) 1998-06-18
IL125776A (en) 2003-12-10
DE19652183C1 (de) 1998-02-12
NO975858L (no) 1998-06-15

Similar Documents

Publication Publication Date Title
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
TR200002207T1 (tr) Slekoksib bileşikleri.
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
BR0009718A (pt) Processo de tratamento
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE427103T1 (de) Orale verabreichung von adenosin analogen
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
DE60019334D1 (de) Antivirale arznei
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
EE04606B1 (et) H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks
ATE243196T1 (de) Piperidine und pyrrolidine
KR970025615A (ko) 암 전이 억제제
HRP20010684B1 (en) Directly compressible matrix for controlled release of single daily doses of clarithromycin
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
EP0657167A3 (fr) Application de l'oenothéine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, les compositions pharmaceutiques le contenant et un procédé de préparation à partir d'Epilobium Parviflorum.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
ATE233745T1 (de) Arzneistoffe
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
IL70407A (en) Synergistic analgesic pharmaceutical compositions in unit dosage form,comprising an analgesic agent and hydroxyzine
AR015537A1 (es) Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050613

MM4A Lapse of definitive patent protection due to non-payment of fees